<SEC-DOCUMENT>0001683168-17-001609.txt : 20170619
<SEC-HEADER>0001683168-17-001609.hdr.sgml : 20170619
<ACCEPTANCE-DATETIME>20170619083005
ACCESSION NUMBER:		0001683168-17-001609
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170615
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170619
DATE AS OF CHANGE:		20170619

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIMULATIONS PLUS INC
		CENTRAL INDEX KEY:			0001023459
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				954595609
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32046
		FILM NUMBER:		17917530

	BUSINESS ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
		BUSINESS PHONE:		661-723-7723

	MAIL ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>simulations_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>UNITED STATES</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">FORM 8-K</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 15, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">(Date of the
earliest event reported)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">Simulations Plus, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">(Exact name
of registrant as specified in its charter)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">001-32046</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">95-4595609</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(Commission File Number)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">42505 10<SUP>th</SUP> Street West, Lancaster,
California 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">(Address of
principal executive offices) (Zip Code)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">661-723-7723</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">Registrant's
telephone number, including area code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Wingdings">&#111;</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Wingdings; font-weight: normal">&#111;</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Soliciting material pursuant to Rule 14z-12 under
Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Wingdings">&#111;</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Pre-commencement communications pursuant to Rule
14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Wingdings">&#111;</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Pre-commencement communications pursuant to Rule
13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Emerging growth company&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.&nbsp; <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Other
Events</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 15, 2017, Simulations Plus, Inc., a
California corporation (the &quot;Company&quot;), issued a press release announcing preliminary revenues for the third fiscal quarter
of fiscal year 2017 ended May 31, 2017. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The information contained in this Current Report
on Form 8-K shall not be deemed to be &quot;filed&quot; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &quot;Exchange Act&quot;), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;), or the Exchange Act,
except as shall be expressly set forth by specific reference in such a filing. The information set forth in this Current Report
on Form 8-K shall not be deemed an admission as to the materiality of any information in this report on Current Report on Form
8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Current Report on Form 8-K may contain
forward-looking statements that are made pursuant to the safe harbor provisions of Section 21E of the Exchange Act. The forward-looking
statements in this Current Report on Form 8-K are not historical facts, do not constitute guarantees of future performance and
are based on numerous assumptions which, while believed to be reasonable, may not prove to be accurate. Any forward-looking statements
in this Current Report on Form 8-K do not constitute guarantees of future performance and involve a number of factors that could
cause actual results to differ materially, including risks more fully described in our most recently filed Quarterly Report on
Form 10-Q and Annual Report on Form 10-K. The Company assumes no obligation to update any forward-looking information contained
in this Current Report or with respect to the announcements described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.75in; text-indent: -0.75in">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Press
release issued on June 15, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIMULATIONS PLUS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: June 16, 2017</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: <U>/s/ John R. Kneisel</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John R. Kneisel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: left; margin-bottom: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>simulations_8k-ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For Further Information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">42505 10<SUP>th</SUP> Street West</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Lancaster, CA 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt"><B>CONTACT</B>:</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><U>Simulations Plus Investor Relations</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><U>Hayden IR</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Ms. Renee Bouche</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Mr. Cameron Donahue</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">661-723-7723</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">651-653-1854</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">renee@simulations-plus.com</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">cameron@haydenir.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For Immediate Release:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">June 15, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Simulations Plus Reports Record Preliminary
Revenues for Third Quarter FY2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>LANCASTER, CA, </B>June 15, 2017 <B>&ndash;
</B>Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and
development, today released preliminary revenues for the third quarter of its fiscal year 2017, the period ended May 31, 2017 (3QFY17).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. John Kneisel, chief financial officer of
Simulations Plus, Inc., stated: &ldquo;In accordance with our policy to release timely financial information to our shareholders,
we are releasing preliminary revenues for 3QFY17. Earnings will not be released until just prior to the filing of our quarterly
report on Form 10-Q. We expect to file our 10-Q with the U.S. Securities and Exchange Commission on or before the July 10, 2017
deadline.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Kneisel continued, &ldquo;Next quarter will
be the last time we will release preliminary revenues at the end of the quarter, likely occurring at the end of September. With
the continued growth of the Company, the revenue mix has shifted from mostly software, for which revenue recognition is straightforward,
to a much higher percentage of consulting projects over three divisions. Compiling revenues for a variety of contract types and
master services agreements is now much more complicated. As a result, beginning with the new fiscal year we will adjust our policy
and follow the approach of the majority of public companies, releasing our complete results in conjunction with the filing of our
periodic results on Form 10-Q and 10-K with the SEC.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Preliminary results for the quarter:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Preliminary revenues for the three months ended May 31, 2017, were $6.69 million, compared to $6.01
million for the same period in 2016. This represents an increase of 11.3%, or $680,000.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Preliminary revenues for the nine months ended May 31, 2017, were $17.82 million, compared to $16.01
million for the same period in 2016. This represents an increase of 11.2% or $1.8 million.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Approximately 71.2% of 3QFY17 revenues were from software and software-related training services.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">Software and software-related services were up approximately 4.9% for 3QFY17 compared to 3QFY16.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Approximately 28.8% of 3QFY17 revenues were from consulting services and analytical studies including
collaborations.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">Lancaster analytical study and collaboration revenues were approximately $219,000 for 3QFY17 increasing
by $66,000, or 43.5%, compared to 3QFY16.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD STYLE="text-align: justify">Buffalo preliminary revenues increased by 29.4%, or $397,000, to $1.74 million for 3QFY17 from
$1.3 million for 3QFY16.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">During 3QFY17, the company added 20 new software customers and a total of 63 for the nine months
ended May 31, 2017.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Cash remains strong: as of May 31, 2017, cash was $8.2 million. Consolidated cash as of June 12,
2017, was $5.6 million. On June 1, 2017, the Company acquired DILIsym Services, Inc. of Research Triangle Park, North Carolina,
and approximately $5 million of acquisition-related payments were disbursed subsequent to May 31, 2017. In addition, during the
quarter ended May 31, 2017, the Company made a dividend distribution of approximately $862,000 on May 15, 2017, and the final payment
of $1,000,000 to TSRL was made in April.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">John DiBella, vice president for marketing
and sales of Simulations Plus, said: &ldquo;Our record third quarter revenue numbers were driven by the sustained increase in requests
for consulting services in both Buffalo and Lancaster. To meet this strong demand, we added several scientists to our teams in
the third fiscal quarter. While we also achieved growth in software and software-related services in the third quarter, it was
below our normal levels, as our software renewal revenue was impacted by the merger of two companies and the resulting synchronization
of software licenses that would have been an additional $110,000. We still delivered 20% growth in the number of license units
sold, achieved robust sales performance in Asia, and continued to penetrate into non-pharmaceutical markets. With the recent release
of GastroPlus&trade; v9.5, expected new versions of PKPlus&trade; and MembranePlus&trade;, and workshops scheduled in Korea, the
United States, and Japan this fall, and of course the acquisition of DILIsym Services, Inc. that we expect to add to revenues and
earnings, we look forward to ending our fiscal year 2017 on a high note.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dr. Ted Grasela, president of Simulations Plus,
added, &ldquo;Our clients recognize the value of the synergies between Buffalo and Lancaster as reflected in the growing demand
for our services. I look forward to building high-value relationships with our new colleagues in DILIsym.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Walt Woltosz, chairman and chief executive
officer of Simulations Plus, said: &ldquo;The third fiscal quarter is yet another in a long string of record quarters for Simulations
Plus, with growth on all fronts. The especially strong growth in consulting services in both Lancaster and Buffalo is evidence
of the value our scientific teams provide. We now begin our first quarter including our DILIsym Services, Inc. division in Research
Triangle Park, North Carolina, and we expect additional growth in both revenues and earnings from that division.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>About Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Simulations Plus, Inc. is a premier developer
of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting
services for regulatory submissions. The company is a global leader focused on improving the ways scientists use knowledge and
data to predict the properties and outcomes of pharmaceutical and biotechnology agents. Our software is licensed to and used in
the conduct of drug research by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. Our innovations
in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology
into our software have made us the leading software provider for physiologically based pharmacokinetic modeling and simulation.
For more information, visit our website at www.simulations-plus.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Safe Harbor Statement Under the Private
Securities Litigation Reform Act of 1995</B> &ndash; With the exception of historical information, the matters discussed in this
press release are forward-looking statements that involve a number of risks and uncertainties. Words like &ldquo;believe,&rdquo;
&ldquo;expect&rdquo; and &ldquo;anticipate&rdquo; mean that these are our best estimates as of this writing, but that there can
be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ
significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to:
our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by
our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to
attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company,
and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports as filed with
the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Follow us on Twitter <FONT STYLE="color: blue"><U>| </U></FONT>LinkedIn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">###</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  R 0@# 2(  A$! Q$!_\0
M'    @,! 0$!              <$!08#" (!_\0 .A   0,# P(#!0<"!04
M     0(#!  %$082(0<3,4%1%")A<8$(%2,R4I&A,[$6%R0T0F)C@L'A_\0
M&0$!  ,! 0                $"! ,%_\0 *1$  @(! P,#! ,!
M  $" Q$$(3$206$448$30E*1<:'A\/_:  P# 0 "$0,1 #\ ],:@O,*P6F1<
M;F\&HK(RI7F?@/4TG+M]H6 UN3;+.\]Z*>=#?\8-6/VF"\]IFT0V5[1)GH1C
MRSX _P FL+JW_ G3&Y-6:1IIR^75+"77I$E0V*)'EDUZ6EHKE!.2<F\[?P9+
MK)]347A(EQOM!W/VK+]KBJC$XPA1W)^OG6WB]8VU >TVE0!Y"D/9R/EBE7U(
M?T%=M$P;KI=N) OI4DN0F.%!).%!6..,?S5>VL)9C A6"$).$D\$@5MCI:+(
MYZ,&"_474M8ED?D/JQ8G2!(:EL$_]&X?O6ZMLZ-<834N$ZEV.Z-R5I\"*\[]
M1[#!TW-M;< N[)<</+[BBKGX>E,_H>I2M'+RHD"2O&?+@5AU.FKC4K:S3IM3
M9*UU68&"I24)*E*"0/,G%057FVA>PSXP5X8[@I,?:&O3[E_L.G!,7#@25)7)
M6DXX*@GGU !S]*G+Z4]/Y%J6W GMKF%O\-XS\^_C@D9_BN,=/%0C.QO?V1I=
MLG)QBN/(Y0ZV6NZ'$%L#.X'C'SKYCR&9+?<CNH=1X;D'(I1::LZ^GW36\-:W
ME^T6YQ0"417"2$*X(23CQR*OK;?-,:#Z>0)T)B4Q:'CEIL^\X2H^>35)4?AO
MOA>2RM_+;88E%+6=UETS%<:*4SWHR\?ZEN.>TDGRW'&?IFNMXZOZ:MRD%OVR
M:P0"I^.R2VC/D5' S4>FM_%D_6K]QBT5F9FM[-&T>G4H?4[;%I!2I"?>/EC!
M\^*G0]00Y6F$7Y(<1!5']I&\85LQGPKFZY)9:\%^N+[ENI00DJ40$@9)/E7.
M/(9DM[X[J'49QN0<C-+?56N(-\Z1WJ[VL/(8=:7&074[3N4,9'[U#Z<76U:#
MZ0VN=>GQ';D_C!.,J6M?D!Z\5U]/+HR^<XP4^JNK';&1LT4L$]9["A2%3;?>
M(499]V3(BE+9'KG-<.LG4E>F[9&CV)2Q<I(;>;?4SN:[1)SR>,\>%(Z6UR4<
M<AWP2<L\#6KBW*CN/J9;>;4\C\R H$CYBL'HGJ1$O2H-O?BW),]3&YY]V*6V
M]R4Y4<^0X-1= R]'NW'4>HK0B0PXA93-DR%$H]WD[>3@5#HE'/4GL%:GCI&9
M12P=ZTZ="E*C1+K*CI.#(9C$M_N36LLNL[->=-2;[ D%<*,A:WLIPI&T9((]
M<565%D%F425;"6R9HZ*6O^<NFEVY,J,W<)*B2%,LQRI: /\ DKR ^M:/3>N+
M'J"PR+O#E;(L;/M'=&"U@9Y_^4E19%9<6%;"3PF:>CXTL7.LUCPIR);;U+B)
M\93,4EK'KDFM-;-7VO4&D)=YM+Q<C(0M)R,%*@/ _O4RHLCO)!6P?#+\W"&"
M093((X/OBOMF4P^2&7FUGT2H&DOTVT3 U-:9-PNP>WJ>(1L64@C&3_.:Y:EL
M+&EM9V:/I]]]#SR@2DK)(Y_]\UH]+7UNM2W7@R^JLZ%8X[/R.XOLI>#*G4!U
M7@@GD_2NM*J,ZB;UAN<YS^A;(Q43Z;4[36]TQJ&'J."Y+MX<#*'"V2XG&2 #
MQ\.:SVTN"3\+^SO5<IMKR_Z+BBJ"TZLMMSDW%IA2TB!GO.+&$CZU3.=2K5E9
MBP[E+83G+S+&4?/-0J+&\)%G?6EELW%%4VF=1V[4D5;]L=*PV=JTJ&"D_&BN
M<HN+Q);G2,E)9B]A:?:70MS3]D0RK8\J>E+:OTJ\C6,U=U&NFGKJBTZ]TK9+
MC<FFDDR0!^(DC@@G^13,Z^Z<G:AT4/NMM3LF&\F1VT?F4!X[?CX4F6NJVH(\
M=N'J.QV^[=E.SN2F2ES'Q/->MI8_4JCA)XSWPS%=+HF\O&<%]K:RZ:U'T=3K
M2S69JT3D?B8;XW *(*3C@@XK]TGK96G[%&@"S0YHW!7=> *O>(X^E9'6_4^Y
M:KT^W8F[;%MENW)):8.XKP>$CPP*ZM-K#+22A1*4IX"3XBME=+Z.FWWV6>/D
MPZJ[$E*M[CLZBZQ^XY%I0;+"FB3&#N7D@E'P'PJTZ.O^U:<F2@VED/S7'.TC
M\J,A/ ^%)AUJ_P!_=8[S<R<M"0AK*/RI]!3VZ96.58-+HC3L"0XXIU21_P <
MXX_BL&IKA31T_<:--9.Z]R^TQVHKOI#66NG=+Z@M67X@*437'M@SC)2,$&LS
MU*Z?Z)T[I69/MLM3$Y"?].AN1N*U^0QXXIF:IZ8::U+<UW"='>:F+QO=CN;"
MK P,\&JJ+T;T='DI+R9<I0.0W)D[P?IBJ5ZBN'2XR:2[?\S3.J<LY2?D6&HI
M$T]$-+VV<\Z[(N4T%)<42HLG.WZ<BM'UIC]QC0NE6^"XMM"T#S& G^X-,W4&
MB[#?9UI=G)4E=L(]F:;<"4CD$93]!72]:1LUTU1;[_/+AGP0$L?B (&%$CCY
MFH6KAE2]LOY? =$L-?PC"?:"$:V=/K?:HC#+7?E-M(2A  2D @X_<5*ZAQH>
ME^ARXC49E"O9V6MNP>\LE.Y7S\3FMGJS1]GU:_;W+MW5F$LN-);<P"20>1CG
MP%=-9Z7M>K+6B%>5.",AS?\ AN!'/Q-<X7Q2A%]GEEY52;DUW6$(_7239>AN
ME+024N3'4N+SYX.3_"A6_P"J=TA::Z1KM[<EH2'(S<:.A*P2O&,D?# /-:S4
MND;%J.Q1[;<VPJ(P &5I6 I&!C@_05G6^CND5VU453<M\*4#WER-RP/T@XP!
M]*Z*^N72YYV;95U36>GNL"XUHVJT="=+V9M)#T]T*QYJ.[>/X(K4:PNRHMUT
MYHBSVNWS+B&$*#LY.Y#((X('K[IK?7W0UEO/W09Z7MEJV^SI2YA("0 ,\<^%
M1M7Z T]JV0W,N'=;E,IV"1%>V+V^0)YHM36\=7E_+X(=,EG'A?H4O6)6J8]H
MM]@U!+M<Q$Y](:7&1L<0?(;?T_'%6?5YI$J^:"TPDI2G*2X%''!P!D_^)K;Q
M>E6E&WX$E(DO/P7 ZEUR1O*B#D;SY\_*K/6FB-/:P7'<NVY+[ PAYAT(6!Z9
MYJ8ZFM./C/;N_!#IFT_."!?];6?LZGMD%69EN@K6ZL(PA)/NA.[PSE0XI-@N
MVG[.Y<3N2[>)V]2O#*<A)_?;3KA=-]-1]-S[)%;=]GG;?:70[EUS:01E6/45
M8O:)L4G2;.G'XW=MC  0E2O>2<YSGUR:K7?57A1SRG^O]+2JG/=^S*1E=JTM
MTB22J+V&H&,C:0XHIQ]3DTL=.!RP?9VNTUT%"[BX0E)&"05!O^V:84?HOI)I
MU"EFX/MYX9=E;FS\,8K3ZHTA9+_8F+-/"F(#.WMM,K", #@?*BOKCMEO+RPZ
MIRWXPL(S73RWQ-,](&9*X[0>,13[ZBD963GQ_BEWH*%;T]%KP;O<F[6B]RNV
MB0L<;D'(X]/=/TI[W6RVZ=IQVQR5%N ZSV"$+"5;/@:JE]/]/O:19TZ[&4[;
M6CO;W*RI*OU ^O)_>JPU,=V\Y;S\(F5+VQV6!8M1->:'T25QIUFE6.(R7$I4
MA(#C9R?/QSGPJX:U )W1-ZX"W1K8Y,46^U&1L0HYSN ^.#5NWT9TLR4E]^Z/
M,(\&7Y>6_EC%:R[:7M%WLD:UN([=OCJ!:;84$@8! '\FKRU%3:;WWRWC!1TV
M=+2]L<F TEI'4B]/Q'8%_3#CNI[B6>V3MR:T%@T&N!>?OJ]7%=PF,I*D$\)2
M1Y_2MQ$89A1&8S.$M,MA"03X) P*'TM2XSK1<!0M)2HH5R :XSU4Y-]D_!:&
MEA%+NUY$M8913I[6U]43N?66TGU"U<_WK9:"DQ;#TSC2Y+S2!VUNJRH<JR<#
MXG@5=VS2UEA6*1:64!R$[DN!:PHGZU5Q.G6FF4/ =YY"DD8<?W!OXCR!KK.^
MJQ-//*_26#E"BVMIK#V?[;R9#1347_+Z]2+G-3#1<GRT'U?J&:EPH6J],:8*
MH,VVOVIAM3J<I "TGGS\<UN&]*V0:;^YRV'+>%;O>6"0KUSZU4,=-+ =I#\]
MYD>#2I.4?+&*GU-<FV^&^,9*^FLBDERE[X)?3.X_>UB5,-MCP5K7@]A&U+F/
M.BM1"B,08K4:(TEIAL;4(3X 45BLDI2<EP;JXN,4GR=ZAW"UP+BC;<(4>2GP
MPZV%?WJ9154VN"[63+1^G^E(\OVEJPP$N^7X(P/D*O(]J@1O]O"CMX_0V!4V
MBK.R;Y950BN$ X'%%%%4+!7GN4(3+MWN3TIN\J:GJ47C*=CW!H@##:&]H! \
ML'!S7H2H3EIMSDKVERWQ%R,[NZIE)7GUSC.: 2-B1IN5IB5=-4W*5'U F:KN
M.I<6)+:PZ E*4>./ 8'&":IX"E7#5G:N+T=]H1G%H3=93C+>>\O!& ?>QC(K
MT*Y:+:Y),ARWPU2"K=W5,)*L^N<9S7[)M%ME$&3;X;Q&<=QE*O'Q\10"="+I
M%UE=+O8'''C9X<0*M[3A4Q)CJ[F\()_Y#:"#\#5/89T2^W6WN7J9).F9LZ<\
MV7UJ0E2][A2E6?#"<<'TKT"Q%CQQAAAIH$!/N(">!X#CRKBY:[>['##D&*M@
M**PVIE)2%'Q.,8S\: 15]194WBW6^P33)M29[P>;FR'&XJ%;&_=2L Y'GZ<F
MF#FYVWIR]_A.-;'9(0\<1I*UMH]TG*%$94K..*V1L]L,=,<VZ&6$DJ#983M!
M]<8QFI$2+'ALAF(PTPT#D(:0$I'T% +"\2+Q,Z2L*U3*%HE.&.%.H*U=T';E
M+N!E 5R%$9P#6,?>@Q+ZQ:G$"% DK:5/=MDUQZ&IG"N%D@;%9QSCGFO0K[+4
MAI33[:'6EC"D+2% CX@U$:M%M:8=9:M\-#+N.XVEA(2O'AD8YH!&ZQ1;K9-N
M<;2,IWV!VU%4A,=U2D!SNX3DCP)X''.*M;UI!$?I]>)LZU,0GF(0=CNPY;BU
ME6WDG(&#\J;[%JMT=#B&($1I#F-Z4,I2%8\,X'-27&FW&BVXA*FR,%)&01Z8
MH!,F/'T5IK2>KHZYB(3+*?O1&]2^XVXV<*4/,]PH_>JI5VO6G(LER0_,<EZN
MCK5;P25=J4I2@A(]!V^T?+FGP[%CO1C'=8:7'( +2D IP/ 8\*'(D9PLER.R
MLL'+6Y /;/JGT^E (35MPE1;@W;;,Y>'TZ7C(#+K 4L/R<C>'#YX2%#S_-7T
MXN1K#7ESFQ+2N[1W+=&?;CO2U,I8*D))2/+.<@_6GVVPTUO[;2$=Q14O:D#<
M3XD^IKY8B1HY)8CLM$C!*$!.?VH#S?IU?WG=XZ;E)BRTHM;1";O*<82VKNN@
MI20#N(P!GY4VM1O:KB0;0C1L6&]'# #GOA21@#&TJP2/C6M?LUK?V]^VPG-H
MPG>PE6!\,BIK3:&FTMM(2AM(PE*1@ >@% *?61N<O2]@1JJ8Q;YZYGXD994F
M-)P1A#BT [1\:HK;<(EKN,=A!,"/&N\=R2N-+6_#VJ:>P$J/ASC(QC.*>,N+
M'F,EJ6PT^T3DH=0%)S\C7!-IMR(JXR+?$3&6<J:#*0A1]2,8- )?J%>$3M7O
M*@W)]=G*8;,Y<9:NVAM4A.\$C@923G'E7QK1-AM$*XHT5<90?=CH,QJ,ZM32
M&-W*\C@+Y\N:=C5KM[+#K#,&*VR[_4;2RD)7\QC!K\CVJW1D.(CP(C2'1M6&
MV4I"QZ' YH!&=16M+6FVK&E+G*1<'VD@L17EJ9<;[B<ETC\OS\:F2(4%NP-(
M1-L\%+TB.%B++>=;D_\ ;?5MRVD^OSIRLV:ULI<2S;83:7$[5A#"0%#T/'(H
M;LUK;:<:;ML)#3N-Z$L) 7CPR,<T BGC"$B3:4N1[>.^PXM#4QUVW2<I7ALK
M RV3XGCD@5N.E#T9J]WV!&CEA37;6L192GX?('],JQA7J,5ODV>V(CKCHMT-
M+"R"ML,)"5'U(Q@UVAPHL%"D0HS$="CDI9;" 3Z\4!(HHHH HHHH HHHH HH
MHH HHHH HHHH HHHH HHHH HHHH HHHH HHHH HHHH HHHH HHHH HHHH HH
,HH HHHH HHHH#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
